EUVIMEDEUVIMED entdecken
Crossref

Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia

Yue Chen, Mengge Pan, Lanxin Chen, Miaoxin Peng, Zhenyu Liu, Yiran Fang, Ying Du, Yonggong Yang, Peipei Xu

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05629-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Yue Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Drum Tower Hospital Clinical College of Jiangsu University, Nanjing, 210008, China. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute promyelocytic leukemia (APL) is a specific subtype of acute myeloid leukemia that is distinguished by the chromosomal translocation t(15;17)(q24;q21), which leads to the fusion of the promyelocytic leukemia (PML) gene with the retinoic acid receptor alpha (RARA). Recently, we identified a novel fusion gene in APL, RARA::ankyrin repeat domain 34C (ANKRD34C), identified its functions by morphological, cytogenetic, molecular biological and multiplex fluorescence in situ hybridization analyses, and demonstrated the potential therapeutic effect clinically and experimentally of all-trans retinoic acid (ATRA); the findings have important implications for the diagnosis and treatment of atypical APL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Promyelocytic, AcuteHumansIn Situ Hybridization, FluorescenceTretinoinRetinoic Acid Receptor alphaCarrier ProteinsTranslocation, GeneticOncogene Proteins, Fusion

Stichwörter der Autor:innen

ANKRD34CAcute promyelocytic leukemiaPML::RARARARA

Substanzen

TretinoinRetinoic Acid Receptor alphaCarrier ProteinsOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Nanjing Drum Tower Hospital Clinical College of Jiangsu University, Nanjing, 210008, China.
  • Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
  • Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, China.
  • Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China. 915834491@qq.com.
  • Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China. xu_peipei0618@163.com.

Zitieren

APA

Chen, Y., Pan, M., Chen, L., Peng, M., Liu, Z., Fang, Y., Du, Y., Yang, Y., & Xu, P. (2024). Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia. Annals of Hematology. https://doi.org/10.1007/s00277-024-05629-8

Vancouver

Chen Y, Pan M, Chen L, Peng M, Liu Z, Fang Y, et al. Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia. Annals of Hematology. 2024. doi:10.1007/s00277-024-05629-8

BibTeX
@article{Chen2024,
  author = {Chen, Yue and Pan, Mengge and Chen, Lanxin and Peng, Miaoxin and Liu, Zhenyu and Fang, Yiran and Du, Ying and Yang, Yonggong and Xu, Peipei},
  title = {Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05629-8}
}
Kostenlos starten →